Home

arrow iconNewsarrow iconarrow icon

FERSOG - Ghana Must Recognize Infertility as Disease

FERSOG - Ghana Must Recognize Infertility as Disease

The Fertility Society of Ghana has urged the government to officially recognize infertility as a disease and include basic fertility services in the National Health Insurance Scheme during its eighth Annual General meeting, held in Tema.

By FertilityIn

09 Dec 2025

3 min read

The Fertility Society of Ghana

The Fertility Society of Ghana

The Fertility Society of Ghana (FERSOG) has intensified calls for the government to officially recognize infertility as a disease, aligning with international health standards set by the World Health Organization (WHO). The society made this appeal during its eighth Annual General Meeting and Scientific Conference, which took place on October 16-18, 2025.



Dr. Rudolph Kantum Adageba, President of FERSOG, described the current healthcare arrangement where couples pay out-of-pocket for infertility services as "unfair, discriminatory and unjust." He emphasized that infertility must be viewed as a public health concern rather than a private financial burden.​



The World Health Organization has defined infertility as a disease and a major disability. As a country, we must see it as such, just as we see other diseases, said Dr. Adageba at the conference, which brought together clinicians, embryologists, nurses, and policymakers under the theme "Reducing the Burden of Infertility in Ghana: Awareness, Preservation, and Infertility Prevention."



FERSOG has submitted a position paper to the National Health Insurance Authority (NHIA) and other stakeholders, advocating for the inclusion of basic infertility services in the National Health Insurance Scheme (NHIS). These services include clinical consultations, semen analysis, hormone profiling, pelvic ultrasound, and intrauterine insemination (IUI). Dr. Adageba noted that the society would continue engaging with the NHIA to establish realistic fees for these services.​



The recognition of infertility as a disease carries significant implications for Ghana's healthcare system. Research indicates that infertility affects approximately 11.8% of women and 15.8% of men in Ghana, with affected couples facing devastating biomedical, psychological, and sociocultural consequences. In Ghanaian society, where children are expected to maintain family lineage and ensure marital stability, the inability to conceive often results in social stigma, discrimination, and psychological distress, particularly for women.​



Currently, Ghana has 22 assisted reproductive technology (ART) centers located in only three of the country's 16 regions, primarily serving middle- and upper-class populations in urban areas. The average cost of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) is approximately 50,000 Ghana Cedis (USD 3,400), far beyond the reach of most Ghanaians, whose national daily minimum wage stands at 19.97 Ghana Cedis (USD 1.4).​



Prof. Dr. Titus Kofi Beyuo, Member of Parliament for Lambussie and member of the Parliamentary Select Committee on Health, announced that the Assisted Reproductive Technologies Bill is at an advanced stage. The Minister of Health is currently working on two key legislative documents: the ART Bill and the Organ Donation and Transplant Medicine Bill. The minister is very committed to passing this bill, Prof. Beyuo assured attendees, encouraging fertility professionals to collaborate more closely with Parliament in their advocacy efforts.​



The conference highlighted that recognizing infertility as a disease would pave the way for regulatory frameworks, standardized care protocols, and financial support through the NHIS. This move would address the current situation where 70.2% of women seeking ART treatment withdraw due to prohibitive costs, and 35.57% discontinue due to partner unavailability.​



FERSOG's advocacy represents a critical step toward achieving reproductive justice in Ghana. By securing disease status for infertility and integrating treatment into the national health insurance scheme, the government could significantly reduce the burden on affected couples and ensure equitable access to fertility care across all socioeconomic classes.

53 views

Share

FertilityIn

Send Enquiry for this Story

Related Articles

Can AI Pick IVF Embryos Better Than Humans?

Can AI Pick IVF Embryos Better Than Humans?

A groundbreaking Nature Medicine study compares AI deep learning against expert embryologists in selecting embryos. While pregnancy rates remain comparable, the study uncovers a massive advantage in efficiency that could revolutionize IVF labs worldwide. Discover how AI-driven embryo selection accuracy is reshaping the future of fertility treatment.

ART

1 min read

FertilAI Secures World's First CE Mark for Predictive AI in Fertility Treatment

FertilAI Secures World's First CE Mark for Predictive AI in Fertility Treatment

FertilAI has received EU MDR clearance for tools advancing Predictive AI in Fertility through its Fertilane platform. StimAI and OvuPredict help clinicians optimise IVF timing, predict ovulation and improve scheduling efficiency. The technology supports scalable fertility care, reduced monitoring needs and better patient treatment experiences globally.

ART

1 min read

Ferring Pharma and Gallup announce Global Fertility Monitor

Ferring Pharma and Gallup announce Global Fertility Monitor

The Ferring Global Fertility Monitor has been launched by Ferring Pharmaceuticals and Gallup to examine fertility trends in 70 countries. Through large-scale surveys, the project will explore economic, social, and cultural influences on parenthood decisions. Insights are expected to guide policy, healthcare planning, and future demographic strategies.

ART

1 min read

Maven Clinic Expands Fertility and Family Building Program with New Diagnostic Tools and Wearable Data Integration

Maven Clinic Expands Fertility and Family Building Program with New Diagnostic Tools and Wearable Data Integration

Maven Clinic has expanded its Fertility and Family Building program with earlier diagnostics, wearable integration, and AI-powered personalised care. The enhanced platform supports faster diagnosis, improved treatment decisions, and condition-specific pathways for PCOS, endometriosis, and oncofertility. The rollout continues through 2026 with added innovations and partnerships.

ART

1 min read

Debate Goes on the Legalization of Egg Donation in Germany

Debate Goes on the Legalization of Egg Donation in Germany

Germany is debating the legalization of egg donation in Germany, challenging decades-old restrictions under the Embryo Protection Act. Experts argue reform is overdue to align with modern reproductive science, reduce fertility tourism, and improve patient care, while policymakers work to balance ethical concerns with growing demand for advanced fertility treatments.

ART

1 min read

New Research Links Forever Chemicals to Reduced ART Outcomes

New Research Links Forever Chemicals to Reduced ART Outcomes

A new review highlights the link from Forever Chemicals to reduced ART outcomes, showing how PFAS exposure impacts fertility, pregnancy, and reproductive health. The findings raise urgent concerns for IVF patients and call for stronger regulation, deeper research, and systemic action to address environmental risks in reproductive medicine.

ART

1 min read

Addressing the Infertility Crisis: New Directions in the 2027 Title X NOFO

Addressing the Infertility Crisis: New Directions in the 2027 Title X NOFO

The 2027 Title X NOFO introduces a major policy shift toward addressing infertility crisis in the U.S. It mandates basic infertility services, expands male reproductive health focus, and promotes education on body literacy and lifestyle factors, aiming to support family formation alongside traditional contraceptive services.

ART

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address